TRB3在糖尿病腎病腎小管細胞中的表達及意義
[Abstract]:Research background and research purpose
Diabetic nephropathy (DN) is one of the most common and serious complications of diabetes mellitus (DM). According to statistics, 30% of diabetic patients will develop end-stage renal disease, so it is necessary to study its pathogenesis. For a long time, people have focused on glomerular damage, but later studies have shown that renal tubular damage. It plays an important role in the occurrence and development of DN, because studies have found that renal tubular damage exists when the urinary albumin excretion rate of diabetic patients is within the normal range.
Tribbles is a newly discovered mitotic-suppressing nuclear gene, also known as neuronal death-inducible protein kinase, found in Drosophila by Grosshan et al. TRB3 is a member of the TRB family, a mammalian homologue of Tribbles. Like other members of the family, TRB3 contains an evolutionarily conserved kinase-like domain, but due to lack of it. The key amino acid residues and ATP binding sites that play a catalytic role have not been found in the existing experimental studies. TRB3 has a wide range of biological activities, including increasing insulin resistance and regulating cell proliferation, and plays a role in many cell transduction pathways, known as Akt pathway, CDC25/String pathway and M. Recent studies have reported that TRB3 silencing can ameliorate myocardial fibrosis in diabetic rats. Morse et al. found that TRB3 expression increased in the kidneys of streptozotocin-induced and spontaneous diabetic mice.
Apoptosis is considered to be an important aspect of the pathogenesis of diabetic nephropathy, because it leads to the decrease of renal volume and function. Therefore, we propose that TRB3 may be involved in the hypothesis of apoptosis of DN renal tubular cells.
Based on the above background, the expression of TRB3 in the kidneys of diabetic rats induced by intraperitoneal injection of streptozotocin (STZ) and the relationship between TRB3 expression and apoptosis and fibrosis were studied in this study.
research method
Eighty male Wistar rats aged 1.8 weeks were randomly divided into control group (30 rats) and diabetic group (50 rats). Diabetic rats were injected with STZ 60mg/kg body weight once intraperitoneally. The control group was injected with sodium citrate buffer intraperitoneally. Hematuria and urine of control group and DM group (7 rats in each group) were collected 8 weeks, 12 weeks, 16 weeks and 20 weeks after modeling. Kidney tissues were examined for each index. Blood glucose, 24-hour urinary protein and serum creatinine were detected by laboratory method; glomerular fibrosis was detected by PAS staining; the expressions of TRB3, fibronectin (FN) and Collagen I (Col I) were detected by immunohistochemical staining, fluorescence quantitative RT-PCR and Western blot. Diabetic rats were randomly divided into diabetes mellitus + blank virus group (DM + vehicle group) and diabetes mellitus + TRB3-siRNA group (DM + TRB3-siRNA group). Ten rats in each group were injected with blank virus and virus carrying TRB3-siRNA respectively. The kidneys were sacrificed after 4 weeks to detect the expression of TRB3, FN and Col I. Albumin stimulated and detected the expression of TRB3 and the secretion of FN and Collagen I. TRB3 was silenced by TRB3-siRNA and the secretion of FN and Col I was detected again to reveal the relationship between TRB3 and TRB3.
40 male Wistar rats aged 2.8 weeks were randomly divided into control group (control group), diabetes mellitus group (DM group), diabetes mellitus + vehicle group (DM + vehicle group) and diabetes mellitus + TRB3-siRNA virus group (DM + TRB3-siRNA group), 10 rats in each group. After 16 weeks, DM+vehicle group and DM+TRB3-siRNA group received tail vein injection of blank virus or virus carrying TRB3-siRNA respectively and were sacrificed 4 weeks later. The expression and apoptosis of TRB3 were detected in kidney tissues of rats. Renal tubular epithelial cells were cultured in vitro, and the expression and apoptosis of TRB3 were detected by albumin stimulation and T lymphocyte apoptosis. RB3-siRNA silenced TRB3 and detected apoptosis again to reveal the relationship between TRB3 and apoptosis, and further explore the role of Akt pathway in this process.
Result
1.TRB3 mediates accumulation of extracellular matrix in renal tubular cells in diabetic nephropathy
1.1 biochemical and histological changes
After STZ injection, the blood glucose, urinary protein excretion and serum creatinine clearance of diabetic rats were significantly increased, and the level of renal hypertrophy index were significantly higher than those of normal rats. PAS staining showed that the kidney of DN rats showed obvious deposition of extracellular matrix in mesangial area, and the level of glomerulosclerosis (GS) was higher than that of normal rats. Obviously increased.
Increased expression of 1.2TRB3 in kidneys of diabetic rats
Immunohistochemical staining showed that TRB3 was not expressed in the kidneys of the control group, but more TRB3-positive cells were found in the kidneys of DM rats. The expression of TRB3 mRNA in the kidneys of DM rats was significantly higher than that of the control group. Western blot showed that TRB3 protein was expressed in the control group. The amount was very low, but the expression increased significantly in diabetic group.
The expression of 1.3Col I and FN increased significantly in diabetic group, but decreased significantly after TRB3 silencing.
The results of immunohistochemistry and Western blot showed that the expression of Col I and FN increased significantly in diabetic group, but decreased significantly after TRB3 silencing.
1.4 albumin can induce NRK-52E cells to express TRB3..
1.5 albumin could induce NRK-52E cells to secrete Col I and FN, and TRB3 secreted and secreted less.
Detection of Col I and FN by ELISA showed that albumin increased the secretion of both, while TRB3-siRNA silenced the expression of TRB3 significantly decreased the secretion of both.
2.TRB3 mediates apoptosis of renal tubular epithelial cells in diabetic rats.
Increased expression of 2.1TRB3 in kidneys of diabetic rats
Immunohistochemical staining showed that TRB3 was not expressed in the kidneys of the control group, but more TRB3-positive cells were found in the kidneys of DM rats. The expression of TRB3 mRNA in the kidneys of DM rats was significantly higher than that of the control group. Western blot showed that TRB3 protein was expressed in the control group. The amount was very low, but the expression increased significantly in diabetic group.
2.2 the apoptosis of kidneys in diabetic rats and the effect of TRB3 silence on apoptosis.
In situ TUNEL assay showed that the number of positive cells in control group was very small, but the number of positive cells in DM group was significantly increased, and the positive cells were mainly located in renal tubular cells. The number of TUNEL-positive cells after TRB3-siRNA transfection was significantly lower than that after blank virus transfection. Caspase activity assay also proved this.
2.3 albumin can induce NRK-52E cells to express TRB3..
Albumin stimulated NRK-52E cells, and the expression of TRB3 increased with BSA concentration and stimulation time.
2.4 albumin can induce apoptosis of NRK-52E cells, while TRB3 silence can play a protective role.
The results of ssDNA-ELISA showed that the number of apoptotic cells increased significantly after albumin stimulation, but decreased significantly after TRB3 was silenced and then stimulated by albumin, which indicated that TRB3 mediated the process of apoptosis, and caspase activity also proved this.
2.5 Albumin induces apoptosis by blocking Akt phosphorylation, which can be partially reversed by TRB3 silencing.
Akt pathway is one of the main pathways regulating apoptosis. Albumin stimulation decreases phosphorylated Akt/Akt (p-Akt/Akt), and wortmannin blockades Akt phosphorylation, which indicates that Akt pathway does play a role in the process of apoptosis. After TRB3 silencing, p-Akt/Akt increases significantly, accompanied by apoptosis. The reduction indicates that Akt pathway plays a role in TRB3 induced apoptosis.
conclusion
1.TRB3 was upregulated in renal tubular cells of diabetic nephropathy.
2.TRB3 mediates the secretion of Collagen and FN in renal tubular extracellular matrix in diabetic nephropathy.
3.TPB3 mediates the apoptosis process of renal tubular cells in diabetic nephropathy.
4.TRB3 gene silencing can improve renal tubular cell apoptosis and extracellular matrix accumulation in diabetic nephropathy.
【學位授予單位】:山東大學
【學位級別】:博士
【學位授予年份】:2014
【分類號】:R587.2;R692.9
【相似文獻】
相關期刊論文 前10條
1 黃列軍,曹莜芬;糖尿病的主要危害是什么?[J];中國臨床醫(yī)生;2001年01期
2 梅晰凡,王偉;糖尿病足40例療效觀察[J];中國煤炭工業(yè)醫(yī)學雜志;2001年04期
3 胡懷東,王玉君,龐久高;2型糖尿病患者尿Ⅳ型膠原與糖尿病腎病關系的研究[J];重慶醫(yī)科大學學報;2001年01期
4 盧盛明,戴林,李愛萍;1例糖尿病并發(fā)嚴重多臟器功能障礙綜合征患者治愈分析[J];中國危重病急救醫(yī)學;2001年09期
5 姜醒,苑光軍,馬麗紅;糖尿病的中醫(yī)藥治療近況[J];中醫(yī)藥信息;2001年05期
6 孫德勝,肖螢;超聲評價糖尿病腎病[J];中國醫(yī)學影像技術;2001年01期
7 馬為,郭泉瀅,唐桂軍;以糖腎安為主配合西藥治療糖尿病腎病60例[J];中醫(yī)研究;2001年04期
8 翁小剛;中藥治療3例糖尿病腎病[J];國外醫(yī)學(中醫(yī)中藥分冊);2001年06期
9 周逸丹;;糖尿病飲食治療現(xiàn)狀[J];國外醫(yī)學(老年醫(yī)學分冊);2001年02期
10 滕萬同,楊莉;糖尿病性腹瀉42例治療體會[J];山東醫(yī)藥;2002年16期
相關會議論文 前10條
1 沙洪;肖誠;趙婷婷;郭景珍;黃小潔;王萍;李平;;糖尿病腎病的健康教育[A];中華中醫(yī)藥學會第二十一屆全國中醫(yī)腎病學術會議論文匯編(下)[C];2008年
2 楊麗平;李平;;糖尿病腎病合并貧血的相關發(fā)病機制[A];中華中醫(yī)藥學會第二十一屆全國中醫(yī)腎病學術會議論文匯編(下)[C];2008年
3 周海鷗;王黎芳;楊佳琦;錢大昕;陳士華;;社區(qū)糖尿病病人現(xiàn)狀分析與對策[A];浙江省醫(yī)學會醫(yī)學微生物與免疫學及醫(yī)學病毒學學術年會論文匯編[C];2009年
4 葛菲菲;;糖尿病腎病早期診療進展[A];第10屆全國中西醫(yī)結合腎臟病學術會議論文匯編[C];2009年
5 李桂芝;于道蘭;;糖尿病腎病的飲食調理[A];中華護理學會全國第6屆重癥監(jiān)護護理學術交流暨專題講座會議論文匯編[C];2009年
6 金礫;;淺談糖尿病的護理[A];第十四次全國中西醫(yī)結合瘍科學術交流會論文匯編[C];2009年
7 奚九一;;糖尿病足有二種壞死很難分辨,奚氏中醫(yī)辨證可區(qū)別[A];中華中醫(yī)藥學會周圍血管病分會2010年學術大會論文集[C];2010年
8 高繼寧;趙怡蕊;李躍進;;糖尿病腎病的中西醫(yī)結合治療新進展[A];第十一屆全國中西醫(yī)結合腎臟病學術會議論文匯編[C];2010年
9 蘆文娟;方敬愛;孫艷艷;張曉東;劉文媛;常沁濤;王蕊花;王月香;李慧;劉婷;;抗壞血酸與糖尿病腎病[A];第十一屆全國中西醫(yī)結合腎臟病學術會議論文匯編[C];2010年
10 簡桂花;盛曉華;汪年松;;中西醫(yī)結合治療糖尿病腎病療效觀察[A];第十一屆全國中西醫(yī)結合腎臟病學術會議論文匯編[C];2010年
相關重要報紙文章 前10條
1 馬明愈;現(xiàn)代生活方式導致 糖尿病發(fā)病率迅速上升[N];中國婦女報;2005年
2 主持人 向紅丁博士;糖尿病腎病須早防早治[N];人民政協(xié)報;2002年
3 華悅;預防糖尿病,從減肥開始[N];上海中醫(yī)藥報;2004年
4 劉冬梅;肥胖糖尿病第一誘因[N];天津日報;2004年
5 李學燕;中藥輔助治糖尿病腎病[N];健康時報;2007年
6 李旭紅;中醫(yī)幫您遠離糖尿病[N];市場報;2007年
7 呂洋;糖尿病患者警惕血管病變[N];衛(wèi)生與生活報;2007年
8 記者 崔昕;中藥早期防治糖尿病腎病取得突破性進展[N];中國醫(yī)藥報;2006年
9 崔昕;《糖尿病中醫(yī)防治指南》發(fā)布[N];中國醫(yī)藥報;2007年
10 記者 周穎邋高新軍;防治糖尿病首部中醫(yī)指南發(fā)布[N];中國中醫(yī)藥報;2007年
相關博士學位論文 前10條
1 尹士男;40歲以下發(fā)病2型糖尿病患者的臨床和分子遺傳學特點初步分析[D];中國人民解放軍軍醫(yī)進修學院;2002年
2 職心樂;天津市2型糖尿病及其并發(fā)癥患病率調查及相關危險因素研究[D];天津醫(yī)科大學;2007年
3 付文金;尿液組織因子促凝活性檢測方法的建立及其在糖尿病腎病中的應用研究[D];南方醫(yī)科大學;2011年
4 孫曉澤;中醫(yī)辨證治療早期和臨床期糖尿病腎病的臨床研究[D];廣州中醫(yī)藥大學;2011年
5 苑迅;糖腎康治療糖尿病腎病機理研究[D];黑龍江中醫(yī)藥大學;2002年
6 李偉華;澳門與廣州地區(qū)2型糖尿病中醫(yī)證型特點比較與探討[D];廣州中醫(yī)藥大學;2012年
7 王俊杰;香港地區(qū)2型糖尿病的中醫(yī)證型特點[D];廣州中醫(yī)藥大學;2012年
8 徐亞蘭;2型糖尿病腎臟損害與糖尿病視網膜病變相關性的臨床和病理研究[D];中國協(xié)和醫(yī)科大學;2008年
9 丁丹;胃腸外科手術治療糖尿病血清蛋白質組學研究[D];第二軍醫(yī)大學;2011年
10 郭茂田;中西醫(yī)結合診治糖尿病的現(xiàn)狀及發(fā)展前景[D];南京中醫(yī)藥大學;2004年
相關碩士學位論文 前10條
1 張雙;糖尿病伴發(fā)貧血的影響因素分析[D];浙江大學;2009年
2 李燕玲;雙重糖尿病臨床特征的探討[D];中南大學;2009年
3 孫永勝;2型糖尿病腎病臨床調查分析[D];遵義醫(yī)學院;2009年
4 吳楠;2型糖尿病住院患者慢性腎臟病診斷方法初探[D];復旦大學;2010年
5 蘇麗麗;尿液的表面增強拉曼光譜檢測用于糖尿病的研究[D];大連理工大學;2011年
6 肖憬;2型糖尿病腎病患者白介素-8、白介素-10的變化及臨床意義[D];蘭州大學;2011年
7 黎雅清;2型糖尿病患者心率變異度與糖尿病腎病的關系[D];暨南大學;2005年
8 卜彥屏;糖尿病足危險因素探討[D];天津醫(yī)科大學;2002年
9 陳寬林;血清轉化生長因子β_1與2型糖尿病腎病相關性臨床研究[D];福建醫(yī)科大學;2002年
10 馬文革;社區(qū)2型糖尿病患者治療行為調查及健康教育干預效果研究[D];安徽醫(yī)科大學;2004年
,本文編號:2178322
本文鏈接:http://sikaile.net/yixuelunwen/mjlw/2178322.html